Trail Ridge Investment Advisors, LLC Abbott Laboratories Transaction History

Trail Ridge Investment Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 16, 2024	SELL	$90.19 - $110.4 $6,313 - $7,728	-70 Reduced 1.62%	4,260 $468,000
Q3 2023 Nov 14, 2023	SELL	$95.53 - $114.62 $72,984 - $87,569	-764 Reduced 15.0%	4,330 $419,000
Q2 2023 Aug 14, 2023	SELL	$100.78 - $112.29 $10,682 - $11,902	-106 Reduced 2.04%	5,094 $555,000
Q1 2023 May 12, 2023	SELL	$96.86 - $114.01 $58,019 - $68,291	-599 Reduced 10.33%	5,200 $526,000
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $35,457 - $41,596	373 Added 6.87%	5,799 $636,000
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $61,829 - $71,587	-639 Reduced 10.54%	5,426 $565,000
Q2 2022 Aug 02, 2022	SELL	$102.07 - $123.37 $3,878 - $4,688	-38 Reduced 0.62%	6,065 $659,000
Q1 2022 May 16, 2022	BUY	$114.02 - $139.04 $45,722 - $55,755	401 Added 7.03%	6,103 $722,000
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $658,752 - $806,604	5,702 New	5,702 $802,000

3,186

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Trail Ridge Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Trail Ridge Investment Advisors, LLC with notifications on news.